NYSE · Financial Statements

Glass House Brands Inc. (GLAS) Revenue, Earnings & Financial Statements

$1.62 NYSE: GLAS Market Cap $142.56M

Data as of Nov 17, 2026 (intraday, delayed) · Statements through the quarter ended Sep 2026 · Source: Financial Modeling Prep (methodology)

Glass House Brands Inc. most recently reported annual revenue of $182.0M, a net loss of $30.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Income Statement — 5 Years (USD millions)

Metric20212022202320242025
Revenue————$182.0M
Operating Expenses————$197.0M
Operating Profit————−$15.0M
Operating Margin————-8.0%
Other Income————−$2.0M
Interest$0$0$0$0$7.0M
Depreciation————$16.0M
Profit Before Tax————−$17.0M
Tax rate (%)————-70.1%
Net Profit————−$30.0M
EPS$—$—$—$—−$0.55

Quarterly Results — Last 5 Quarters (USD millions)

MetricSep '25Dec '25Mar '26Jun '26Sep '26
Revenue$38.0M$39.0M$39.0M$47.0M$57.0M
Operating Expenses$50.0M$52.0M$52.0M$50.0M$65.0M
Operating Profit−$11.0M−$13.0M−$13.0M−$3.0M−$9.0M
Operating Margin-29.6%-32.6%-32.6%-6.4%-15.3%
Interest$2.0M$1.0M$1.0M$0$1.0M
Profit Before Tax−$11.0M−$13.0M−$13.0M−$2.0M−$9.0M
Tax rate (%)-9.6%-23.7%-23.7%-202.9%-11.2%
Net Profit−$12.0M−$16.0M−$15.0M−$7.0M−$10.0M
EPS−$0.19−$0.19−$0.18−$0.09−$0.14

Over the 5 years reported for Glass House Brands Inc., borrowings increased from $48.0M in 2021 to $75.0M in 2025, cash stood at $20.0M in the latest year, shareholders' equity was $0, current assets covered current liabilities 1.79 times.

Balance Sheet — 5 Years (USD millions)

Metric20212022202320242025
Total Assets$288.0M$351.0M$304.0M$311.0M$319.0M
Current Assets$69.0M$39.0M$49.0M$66.0M$68.0M
Cash$51.0M$11.0M$30.0M$34.0M$20.0M
Inventory$7.0M$11.0M$9.0M$14.0M$26.0M
Receivables$2.0M$6.0M$4.0M$7.0M$6.0M
Fixed Assets$199.0M$228.0M$227.0M$223.0M$235.0M
Capital Work in Progress$0$0$0$0$0
Investments$7.0M$4.0M$2.0M$2.0M$0
Other Assets$5.0M$38.0M$0$0$0
Total Liabilities$106.0M$181.0M$174.0M$161.0M$236.0M
Current Liabilities$55.0M$54.0M$87.0M$66.0M$38.0M
Borrowings$48.0M$74.0M$75.0M$69.0M$75.0M
Other Liabilities$58.0M$107.0M$98.0M$92.0M$162.0M
Equity$0$0$0$0$0
Reserves$182.0M$169.0M$90.0M$116.0M$74.0M

For Glass House Brands Inc., free cash flow in the latest year was negative at $16.0M; free cash flow was positive in 0 of 5 years.

Cash Flow Statement — 5 Years (USD millions)

Metric20212022202320242025
Operating Cash Flow————$11.0M
Investing Cash Flow————−$55.0M
Financing Cash Flow————$0
Net Cash Flow————−$14.0M
Free Cash Flow$0$0$0$0−$16.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.03
EV / EBITDA-10.24
FCF Yield-25.50%
Quick Ratio0.70
Interest Coverage-10.09
Return 1Y-70.75%
Return 3Y-66.52%
Return 5Y-64.12%

Glass House Brands Inc. (GLAS) financials — frequently asked questions

What is Glass House Brands Inc.'s annual revenue?

Glass House Brands Inc. (GLAS) reported annual revenue of $182.0M in its most recent fiscal year.

What is Glass House Brands Inc.'s net profit?

Glass House Brands Inc. (GLAS) reported a net loss of $30.0M in its most recent fiscal year.

What is GLAS EV/EBITDA?

Glass House Brands Inc.'s enterprise value to EBITDA (EV/EBITDA) ratio is -10.24. A negative value means EBITDA was negative over the period, so the ratio is not a meaningful valuation measure.

Revenue and earnings of other Drug Manufacturers - Specialty & Generic stocks

TEVA revenue $17.3BZTS revenue $9.5BVTRS revenue $14.3BELAN revenue $4.7BRDY revenue $353.5BALKS revenue $1.5BAMRX revenue $3.0BLNTH revenue $1.5BSUPN revenue $719.0MBHC revenue $10.3BAll Drug Manufacturers - Specialty & Generic stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNYSE High ROE StocksAll stock screens
GLAS Overview GLAS Dividend Run Stock Screener

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.